{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease",
      "version": "1.0.0"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
    },
    "path": "huntington/goh2018.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Corpus Striatum": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Gradual atrophy of the striatum (caudate and putamen) due to neuronal loss is the neuropathological and neuro- radiological  hallmark  of  HD.",
      "key": "290421d14b875e245f492d90fe89a2d3",
      "line": 80,
      "relation": "increases",
      "source": 8,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Corpus Striatum": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Gradual atrophy of the striatum (caudate and putamen) due to neuronal loss is the neuropathological and neuro- radiological  hallmark  of  HD.",
      "key": "51ea2797f1460cf7918d8a2791d571e0",
      "line": 81,
      "relation": "positiveCorrelation",
      "source": 8,
      "target": 17
    },
    {
      "annotations": {
        "Cell": {
          "medium spiny neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neostriatum": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Specific  loss  of  medium spiny neurons in the dorsal striatum, expressing either Dopaminergic type 1 or 2 receptors, is seen as the basis for the clinical phenotype with disease progression (see Figure 1). ",
      "key": "bd5a6fce54f44e3a44cb79fa676850ce",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 8,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Corpus Striatum": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Gradual atrophy of the striatum (caudate and putamen) due to neuronal loss is the neuropathological and neuro- radiological  hallmark  of  HD.",
      "key": "4306362eca286ec90e60bb035a2f364f",
      "line": 82,
      "relation": "positiveCorrelation",
      "source": 19,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Corpus Striatum": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Gradual atrophy of the striatum (caudate and putamen) due to neuronal loss is the neuropathological and neuro- radiological  hallmark  of  HD.",
      "key": "d3d25af2add32be171e66c3ae0764ae7",
      "line": 81,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "medium spiny neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neostriatum": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Specific  loss  of  medium spiny neurons in the dorsal striatum, expressing either Dopaminergic type 1 or 2 receptors, is seen as the basis for the clinical phenotype with disease progression (see Figure 1). ",
      "key": "80588e2bf46e055dc4ab40a05bc3152e",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Corpus Striatum": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Gradual atrophy of the striatum (caudate and putamen) due to neuronal loss is the neuropathological and neuro- radiological  hallmark  of  HD.",
      "key": "e95696f9e3026365746432447cbb78d4",
      "line": 82,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "29f8d579384a8059419d83ee49688318",
      "line": 107,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "5c4e4eac2cb2fcafe8f05d7571d352fe",
      "line": 108,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "9f7d665f567abed086be9268acc32570",
      "line": 109,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "3e5ad400b1e1852683785d0f307721ea",
      "line": 110,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "de3e8825d9648edbea8968e060499199",
      "line": 111,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "a4a6371b90ee5e21f0e813f8ab060e18",
      "line": 112,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "fc9a5d39762e0e2aac2de73c6d8ef33e",
      "line": 113,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "371d1ab98256e125cda7c49db1f41411",
      "line": 114,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "33b21285ba9604c815f874f77d85977e",
      "line": 115,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "858e769f1bd2f895ea768416b63ee19a",
      "line": 116,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "37500d27fda4d65e7c7331191f7b9a17",
      "line": 117,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Significant cere- bral cortical grey and white matter loss in patients with HD is also common, particularly in frontal zones. 13",
      "key": "90c20ec2f46dc41cbb345bbb647bdaf0",
      "line": 125,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Significant cere- bral cortical grey and white matter loss in patients with HD is also common, particularly in frontal zones. 13",
      "key": "ecfc9b0d21f222da450a3387f0f18f27",
      "line": 126,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "These motor  symptoms  progressively  worsen  during  the course of the disease, and cause significant difficulties for  activities  of  daily  life  and  function,  resulting  in increasing disability (see Table 3).",
      "key": "d888d285427065fcd3924201ec8e6672",
      "line": 136,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The cognitive symptoms in HD primarily reflect a form of subcortical  dementia  characterized  by  memory  deficits, psychomotor slowing and impairment in executive, per- ceptual and spatial skills.",
      "key": "d65369c12ab33deec1cb8af43319c090",
      "line": 144,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The cognitive symptoms in HD primarily reflect a form of subcortical  dementia  characterized  by  memory  deficits, psychomotor slowing and impairment in executive, per- ceptual and spatial skills.",
      "key": "defe4f038bec582eb8de8f8c148aa256",
      "line": 145,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The cognitive symptoms in HD primarily reflect a form of subcortical  dementia  characterized  by  memory  deficits, psychomotor slowing and impairment in executive, per- ceptual and spatial skills.",
      "key": "73699d0da05caf77e542a3aa68768fe5",
      "line": 146,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The cognitive symptoms in HD primarily reflect a form of subcortical  dementia  characterized  by  memory  deficits, psychomotor slowing and impairment in executive, per- ceptual and spatial skills.",
      "key": "cfd3b0c1f0f311b1584796fc25877491",
      "line": 147,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The cognitive symptoms in HD primarily reflect a form of subcortical  dementia  characterized  by  memory  deficits, psychomotor slowing and impairment in executive, per- ceptual and spatial skills.",
      "key": "38343249cc11cf9181680b74cf69dea7",
      "line": 148,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "42ac37f9c890dc527dc9e25dc397616c",
      "line": 107,
      "relation": "positiveCorrelation",
      "source": 16,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "f1954f1b2a02ea398a3adff8e14e2f75",
      "line": 108,
      "relation": "positiveCorrelation",
      "source": 18,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "58fdc1eea067e35be433cdc0fd9602e5",
      "line": 109,
      "relation": "negativeCorrelation",
      "source": 14,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "f57dfb8c397ce7f351191dac88d4badd",
      "line": 110,
      "relation": "positiveCorrelation",
      "source": 15,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "6a08fbbbf819734194ac85ba7507e2c3",
      "line": 111,
      "relation": "positiveCorrelation",
      "source": 21,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "7c1142c3fd301fcac4ab5a9bbb3ad49e",
      "line": 112,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "b6fcaf089e2ab0c9e57ef931b590fb61",
      "line": 113,
      "relation": "positiveCorrelation",
      "source": 12,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "9804550e4c73c34ccc51de823f9cb973",
      "line": 114,
      "relation": "negativeCorrelation",
      "source": 6,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "4adc556c96bdaec851cf3ef5b84533ac",
      "line": 115,
      "relation": "negativeCorrelation",
      "source": 2,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "5fc5151e81a51824fac3dc8594aa7035",
      "line": 116,
      "relation": "negativeCorrelation",
      "source": 5,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The exact mechanism of HD pathogen- esis is currently unknown, but putative theories include excitotoxicity, oxidative stress, impaired energy metabo- lism, mitochondrial dysfunction, inflammatory events, apoptosis,  autophagy,  abnormal  protein–protein  inter- actions,  disruption  of  dopamine,  glutamate,  cannabi- noid and adenosine systems. 11",
      "key": "65a0743276b18e3eef0e2aa8126c7b2e",
      "line": 117,
      "relation": "negativeCorrelation",
      "source": 3,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Significant cere- bral cortical grey and white matter loss in patients with HD is also common, particularly in frontal zones. 13",
      "key": "0e67d0bcb07205144ee3f3bfba84a77d",
      "line": 125,
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "Significant cere- bral cortical grey and white matter loss in patients with HD is also common, particularly in frontal zones. 13",
      "key": "f0781c8a24be6d481748267313e16da4",
      "line": 126,
      "relation": "negativeCorrelation",
      "source": 1,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "These motor  symptoms  progressively  worsen  during  the course of the disease, and cause significant difficulties for  activities  of  daily  life  and  function,  resulting  in increasing disability (see Table 3).",
      "key": "1a86653044b1643b92ad1abae96fc150",
      "line": 136,
      "relation": "negativeCorrelation",
      "source": 7,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The cognitive symptoms in HD primarily reflect a form of subcortical  dementia  characterized  by  memory  deficits, psychomotor slowing and impairment in executive, per- ceptual and spatial skills.",
      "key": "8741ec4fd2b17d5eaae22849670540c9",
      "line": 144,
      "relation": "positiveCorrelation",
      "source": 20,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The cognitive symptoms in HD primarily reflect a form of subcortical  dementia  characterized  by  memory  deficits, psychomotor slowing and impairment in executive, per- ceptual and spatial skills.",
      "key": "ac4ff5cc671b7513b92f5e30f8df9355",
      "line": 145,
      "relation": "negativeCorrelation",
      "source": 13,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The cognitive symptoms in HD primarily reflect a form of subcortical  dementia  characterized  by  memory  deficits, psychomotor slowing and impairment in executive, per- ceptual and spatial skills.",
      "key": "4dcbc2531b17c1a518ef15e8e4bca66c",
      "line": 146,
      "relation": "negativeCorrelation",
      "source": 9,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The cognitive symptoms in HD primarily reflect a form of subcortical  dementia  characterized  by  memory  deficits, psychomotor slowing and impairment in executive, per- ceptual and spatial skills.",
      "key": "14ac73c5eace0aca7b77b3a3e7acfcb7",
      "line": 147,
      "relation": "negativeCorrelation",
      "source": 10,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Goh AM",
          "Loi SM",
          "Looi JC",
          "Velakoulis D",
          "Walterfang M",
          "Wibawa P"
        ],
        "date": "2018-08-01",
        "db": "PubMed",
        "db_id": "30012004",
        "db_name": "Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.",
        "first": "Goh AM",
        "journal": "Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists",
        "last": "Looi JC",
        "pages": "366-375",
        "volume": "26"
      },
      "evidence": "The cognitive symptoms in HD primarily reflect a form of subcortical  dementia  characterized  by  memory  deficits, psychomotor slowing and impairment in executive, per- ceptual and spatial skills.",
      "key": "516cc280478d30be22e0913476db772c",
      "line": 148,
      "relation": "negativeCorrelation",
      "source": 11,
      "target": 17
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(MESH:\"Gray Matter\")",
      "concept": {
        "name": "Gray Matter",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "ec3d8cd3fe21e400949f6f15da400cd6"
    },
    {
      "bel": "a(MESH:\"White Matter\")",
      "concept": {
        "name": "White Matter",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "6e71bab67d66a2370343d976a22bf3b0"
    },
    {
      "bel": "bp(GO:\"D-glutamate metabolic process\")",
      "concept": {
        "name": "D-glutamate metabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "eca8772adca52844c5e7f845059d733f"
    },
    {
      "bel": "bp(GO:\"adenosine catabolic process\")",
      "concept": {
        "name": "adenosine catabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "4c8e2d547a0b0bb34213cc721fc5fb38"
    },
    {
      "bel": "bp(GO:\"apoptotic process\")",
      "concept": {
        "name": "apoptotic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9eb8739869ef0e82697f61a33d3d6afa"
    },
    {
      "bel": "bp(GO:\"cannabinoid biosynthetic process\")",
      "concept": {
        "name": "cannabinoid biosynthetic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "92f0eb3af94de6ec1b6e9d899cfa84d8"
    },
    {
      "bel": "bp(GO:\"dopamine metabolic process\")",
      "concept": {
        "name": "dopamine metabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "8353e9cff94255ef3de802f3e5a0bfa6"
    },
    {
      "bel": "bp(GO:\"motor behavior\")",
      "concept": {
        "name": "motor behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a2dcc4ec00ebc4321e0089baccd16aa5"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"psychomotor behavior\")",
      "concept": {
        "name": "psychomotor behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "e4b08646b35a8d4cb042048b09445b5c"
    },
    {
      "bel": "bp(GO:\"sensory perception\")",
      "concept": {
        "name": "sensory perception",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "52781435a66c730be4fee87fe0d0eaef"
    },
    {
      "bel": "bp(GO:\"visual learning\")",
      "concept": {
        "name": "visual learning",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "508364dd4e91ce606a0b99d21f53e3b4"
    },
    {
      "bel": "bp(GO:autophagy)",
      "concept": {
        "name": "autophagy",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9efc965fac6a195d0fad26eecddaac05"
    },
    {
      "bel": "bp(GO:memory)",
      "concept": {
        "name": "memory",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "e03a718b44a1ff30acea5c31966879a9"
    },
    {
      "bel": "bp(MESH:\"Energy Metabolism\")",
      "concept": {
        "name": "Energy Metabolism",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "5aaa959e5040d4765b684841ad0942e1"
    },
    {
      "bel": "path(CONSO:\"mitochondrial dysfunction\")",
      "concept": {
        "name": "mitochondrial dysfunction",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "14a330b2e354b7af4f380b05664a5728"
    },
    {
      "bel": "path(CONSO:Excitotoxicity)",
      "concept": {
        "name": "Excitotoxicity",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "3c37b0742431ce3c53b58624adcec97c"
    },
    {
      "bel": "path(MESH:\"Huntington Disease\")",
      "concept": {
        "name": "Huntington Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0b49c6361eaf079c0eae0e5aeb347aea"
    },
    {
      "bel": "path(MESH:\"Oxidative Stress\")",
      "concept": {
        "name": "Oxidative Stress",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "5d5071d9dea362c9b9b6ee5de9eb67be"
    },
    {
      "bel": "path(MESH:Atrophy)",
      "concept": {
        "name": "Atrophy",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "7d5394b2784c6e661c25500d859dc266"
    },
    {
      "bel": "path(MESH:Dementia)",
      "concept": {
        "name": "Dementia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "f28d9b02ed1946e87cf8dd666d940c09"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    }
  ]
}